Clinical investigator disqualification
This article was originally published in The Gray Sheet
Executive Summary
FDA proposes revision of its medical device regulations to include provisions for the disqualification of clinical investigators in a Oct. 6 Federal Register notice. The agency had anticipated publishing the rule at the end of June ("The Gray Sheet" June 21, p. 3). Comments on the proposed reg are due by Nov. 5.